TY - JOUR
T1 - Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer
T2 - A multicenter study
AU - Kobayashi, Hirotoshi
AU - Mochizuki, Hidetaka
AU - Sugihara, Kenichi
AU - Morita, Takayuki
AU - Kotake, Kenjiro
AU - Teramoto, Tatsuo
AU - Kameoka, Shingo
AU - Saito, Yukio
AU - Takahashi, Keiichi
AU - Hase, Kazuo
AU - Oya, Masatoshi
AU - Maeda, Koutarou
AU - Hirai, Takashi
AU - Kameyama, Masao
AU - Shirouzu, Kazuo
AU - Muto, Tetsuichiro
PY - 2007/1
Y1 - 2007/1
N2 - Background: The aim of this study was to clarify the characteristics of recurrence and the effectiveness of surveillance tools after curative resection for colorectal cancer. Methods: We enrolled 5230 consecutive patients (stage I, 1367; stage II, 1912; stage III, 1951) who underwent curative resection at 14 hospitals from 1991 to 1996. All patients were followed up intensively, and their outcomes were investigated retrospectively. Results: Of the 5230 patients, 906 developed recurrence. The recurrence rates of stage I, II, and III cancers were 3.7%, 13.3%, and 30.8%, respectively (P < .0001). The curves of the cumulative appearance rate of recurrence in stage II and III patients showed a rapid increase for the first 3 years. Recurrence after 5 years was less than 1% in each stage. Clinical visits combined with measurements of tumor markers detected the majority of recurrences except in the case of lung metastasis. In contrast, 43.4% of hepatic recurrences were detected by liver imaging, and 48.4% of pulmonary recurrences were noted by chest x-ray. The 5-year survival rates after primary colorectal surgery in patients who underwent resection for recurrence were better than in those without resection: 55% vs 11% in hepatic recurrence, 68% vs 13% in pulmonary recurrence, and 48% vs 22% in local recurrence (all P < .001). Conclusion: It is useful to take these characteristics of recurrence into account in the management of patients after curative resection for colorectal cancer and in the setting of clinical trial for follow-up after curative resection for colorectal cancer.
AB - Background: The aim of this study was to clarify the characteristics of recurrence and the effectiveness of surveillance tools after curative resection for colorectal cancer. Methods: We enrolled 5230 consecutive patients (stage I, 1367; stage II, 1912; stage III, 1951) who underwent curative resection at 14 hospitals from 1991 to 1996. All patients were followed up intensively, and their outcomes were investigated retrospectively. Results: Of the 5230 patients, 906 developed recurrence. The recurrence rates of stage I, II, and III cancers were 3.7%, 13.3%, and 30.8%, respectively (P < .0001). The curves of the cumulative appearance rate of recurrence in stage II and III patients showed a rapid increase for the first 3 years. Recurrence after 5 years was less than 1% in each stage. Clinical visits combined with measurements of tumor markers detected the majority of recurrences except in the case of lung metastasis. In contrast, 43.4% of hepatic recurrences were detected by liver imaging, and 48.4% of pulmonary recurrences were noted by chest x-ray. The 5-year survival rates after primary colorectal surgery in patients who underwent resection for recurrence were better than in those without resection: 55% vs 11% in hepatic recurrence, 68% vs 13% in pulmonary recurrence, and 48% vs 22% in local recurrence (all P < .001). Conclusion: It is useful to take these characteristics of recurrence into account in the management of patients after curative resection for colorectal cancer and in the setting of clinical trial for follow-up after curative resection for colorectal cancer.
UR - https://www.scopus.com/pages/publications/33845509483
UR - https://www.scopus.com/pages/publications/33845509483#tab=citedBy
U2 - 10.1016/j.surg.2006.07.020
DO - 10.1016/j.surg.2006.07.020
M3 - Article
C2 - 17188169
AN - SCOPUS:33845509483
SN - 0039-6060
VL - 141
SP - 67
EP - 75
JO - Surgery
JF - Surgery
IS - 1
ER -
